Search Results - Caravella, Betty Ann

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract CT330: Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

    Abstract CT330: Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC) by Shah, Payal D., Moynahan, Mary E., Modi, Shanu, Hamilton, Nicola, Caravella, Betty Ann, Zamora, Stephen, Dang, Chau, Gilewski, Theresa, Traina, Tiffany, Comen, Elizabeth, Sugarman, Steven M., D'Andrea, Gabriella, Lake, Diana, Goldfarb, Shari, Patil, Sujata, Covey, Anne, Berger, Michael, Lacouture, Mario, Norton, Larry, Hudis, Clifford A., Baselga, Jose, Chandarlapaty, Sarat, Dickler, Maura

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Abstract PD5-3: Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

    Abstract PD5-3: Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC) by Shah, Payal D, Moynahan, Mary Ellen, Modi, Shanu, Caravella, Betty Ann, Datko, Farrah M, Zamora, Stephen, Comen, Elizabeth, Gilewski, Theresa, Sugarman, Steven M, D'Andrea, Gabriella, Lake, Diana E, Goldfarb, Shari B, Patil, Sujata, Covey, Anne, Berger, Michael F, Lacouture, Mario E, Norton, Larry, Hudis, Clifford A, Baselga, Jose, Chandarlapaty, Sarat, Dickler, Maura N

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: